Chartwell Investment Partners’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-11,708
| Closed | -$685K | – | 427 |
|
|
2021
Q4 | $685K | Sell |
11,708
-207
| -2% | -$12.1K | 0.02% | 400 |
|
|
2021
Q3 | $706K | Hold |
11,915
| – | – | 0.02% | 398 |
|
|
2021
Q2 | $1.03M | Buy |
11,915
+6,305
| +112% | +$547K | 0.03% | 372 |
|
|
2021
Q1 | $463K | Sell |
5,610
-300
| -5% | -$24.8K | 0.01% | 401 |
|
|
2020
Q4 | $537K | Buy |
+5,910
| New | +$537K | 0.02% | 399 |
|
|
2018
Q3 | – | Sell |
-77,304
| Closed | -$877K | – | 480 |
|
|
2018
Q2 | $877K | Sell |
77,304
-2,943
| -4% | -$33.4K | 0.03% | 451 |
|
|
2018
Q1 | $783K | Buy |
+80,247
| New | +$783K | 0.03% | 382 |
|